Cochrane Evidence Synthesis and Methods ►

Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: a generic protocol

To determine the effectiveness and toxicity of immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy alone as first-line treatment of advanced non-small cell lung cancer (NSCLC).

This is a protocol.

Health topics:

Cancer > Lung > Non-small cell

Lungs & airways > Lung cancer > Non-small cell

Published:

26 April 2018

Authors:

Syn NLX, Roudi R, Wang LZizhao, Wang L, Loh M, Huang Y, Ou SIgnatius, Soong R, Drilon A, Wee I

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Syn NLX, Roudi R, Wang LZizhao, Wang L, Loh M, Huang Y, Ou SIgnatius, Soong R, Drilon A, Wee I. Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: a generic protocol. Cochrane Database of Systematic Reviews 2018, Issue 4. Art. No.: CD013009. DOI: 10.1002/14651858.CD013009